Browse Title Index


 
Issue Title
 
Vol 4, No 4 (2008): July/August Edema caused by continuous epidural hydromorphone infusion: A case report and review of the literature Abstract
Xiulu Ruan, MD, Riaz Tadia, MD, Hainan Liu, MS, John Patrick Couch, MD, John Keun-Sang Lee, MD, PhD
 
Vol 10, No 4 (2014): July/August Editorial. The prescription opioid abuse epidemic in rural America: A look at how it begins Abstract
Stacey C. Sigmon, PhD, Amanda G. Kennedy, PharmD
 
Vol 10, No 5 (2014): September/October Educational gaps among healthcare providers: An institution needs assessment to improve pain management for postsurgical patients Abstract
Marlís González-Fernández, MD, PhD, Hanan Aboumatar, MD, MPH, Deena Conti, RN, MS, Amit M. Patel, MD, Michael A. Purvin, MD, Marie Hanna, MD
 
Vol 13, No 5 (2017): September/October Educational intervention for physicians to address the risk of opioid abuse Abstract
Margaret K. Pasquale, PhD, Richard L. Sheer, BA, Jack Mardekian, PhD, Elizabeth T. Masters, MS, MPH, Nick C. Patel, PharmD, PhD, Amy R. Hurwitch, PharmD, BCPS, Jennifer J. Weber, PharmD, MS, BCPS, CGP, BCACP, Anamaria Jorga, MD, Carl L. Roland, PharmD, MS
 
Vol 4, No 1 (2008): January/February Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance Abstract
Ankush Singhal, MBBS, MD, MRCPsych, B.M. Tripathi, MBBS, MD, MRCPsych, Hem Raj Pal, MBBS, MD, Renuka Jena, PhD, Raka Jain, MSc, PhD, Cchem, FRSC
 
Vol 15, No 1 (2019): January/February Effect of different doses of remifentanil on stress response during laparoscopic cholecystectomy Abstract
Laura Levantesi, MD, Flaminio Sessa, MD, Elisabetta Congedo, MD, Francesco Di Nardo, MD, Marco Oggiano, MD, Gennaro Canistro, MD, Rossella Sicuranza, MD, Luca Nicosia, MD, Germano De Cosmo, PhD
 
Vol 11, No 2 (2015): March/April Effect of dosing interval on pharmacokinetics of fentanyl pectin nasal spray from a crossover study Abstract
Cuiping Chen, PhD, Shay Bujanover, MD, Anita Gupta, DO, PharmD
 
Vol 2, No 2 (2006): March/April Effect of drug and medical treatment on wide geographic variations in repeated emergency department use by HIV-infected drug users Abstract   PDF
Barbara J. Turner, MD, MSEd, Christine Laine, MD, MPH, Alan Kott, Walter W. Hauck, PhD
 
Vol 7, No 4 (2011): July/August Effect of fentanyl buccal tablet on pain-related anxiety: A 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain Abstract
Lynn R. Webster, MD, John Messina, PharmD, Fang Xie, PhD, Srinivas Nalamachu, MD
 
Vol 9, No 4 (2013): July/August Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases Abstract
Helle Gamborg, RN, Jette Riis, RN, Lona Christrup, MSc (Pharm), PhD, Torben Krantz, MD
 
Vol 16, No 1 (2020): January/February Effect of intrathecal morphine before and after laminectomy on intraoperative surgical stress response and post-operative pain: A prospective randomized study Abstract
Amany Faheem Abd El Salam Omara, MD, Asmaa Fawzy Amer, MD
 
Vol 4, No 2 (2008): March/April Effect of magnesium sulfate infusion on sevoflurane consumption, hemodynamics, and perioperative opioid consumption in lumbar disc surgery Abstract
Nihal Oguzhan, MD, Isil Gunday, MD, Alparslan Turan, MD
 
Vol 16, No 2 (2020): March/April Effect of physical manipulation on the oral pharmacokinetic profile of Xtampza® ER (oxycodone DETERx® formulation): A review of published studies Abstract
Jeffrey Gudin, MD
 
Vol 12, No 3 (2016): May/June Effect of preoperative intravenous oxycodone on sufentanil consumption after laparoscopic radical gastrectomy Abstract
Jinguo Wang, MD, PhD, Yaowen Fu, MD, PhD, Honglan Zhou, MD, PhD, Na Wang, MD, PhD
 
Vol 6, No 1 (2010): January/February Effect of preoperative rectal indomethacin on postoperative pain reduction after open appendectomy Abstract
Ali Jangjoo, MD, Mostafa Mehrabi Bahar, MD, Ehsan Soltani, MD
 
Vol 7, No 5 (2011): September/October Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats Abstract
Elzbieta P. Wala, PhD, Paul A. Sloan, MD, Joseph R. Holtman Jr, MD, PhD
 
Vol 12, No 3 (2016): May/June Effectiveness and tolerability of tapentadol sustained release in the Australian setting Abstract
Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA, Danielle M. Santarelli, PhD
 
Vol 10, No 6 (2014): November/December Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study Abstract
Jesús González-Barboteo, MD, Xavier Gómez-Batiste Alentorn, MD, PhD, Felipe A. Calvo Manuel, MD, PhD, Vicente Alberola Candel, MD, M. Amalia Palacios Eito, MD, Isabel Sánchez-Magro, MD, PhD, F. Javier Pérez Martín, PhD, Josep Porta-Sales, MD, PhD
 
Vol 15, No 5 (2019): September/October Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone Abstract
Joseph S. Gimbel, MD, Richard L. Rauck, MD, Almasa Bass, PharmD, Jacquelyn Wilson, PharmD, Glenn Pixton, MS, Bimal Malhotra, PhD, Gary Wilson PhD, Gernot Wolfram, MD
 
Vol 4, No 6 (2008): November/December Effects of perineural tramadol on sensory and motor conduction of ulnar nerve Abstract
Ertan Öztürk, MD, Murat Zinnuroğlu, MD, Özer Ali Sezer, MD, İsmail Gökyar, MD, Mehmet Beyazova, MD, Kadir Kaya, MD
 
Vol 3, No 5 (2007): September/October Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid® OAD) Abstract
Ritchard L. Fishman, MD, Charles James Kistler, DO, Michael T. Ellerbusch, MD, Raul Tomas Aparicio, MD, Sharad S. Swami, MD, Mark E. Shirley, DO, Adesh K. Jain, MD, Louise Fortier, MSc, Sybil Robertson, BScN, Sylvie Bouchard, MD, PhD
 
Vol 11, No 6 (2015): November/December Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain Abstract
Martin E. Hale, MD, Thomas R. Zimmerman, MD, Eli Eyal, MSc, Richard Malamut, MD
 
Vol 7, No 3 (2011): May/June Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic pain Abstract
Nadav Friedmann, PhD, MD, Vicki Klutzaritz, BS, Lynn Webster, MD
 
Vol 14, No 3 (2018): May/June Efficacy and safety of naloxegol for opioid-induced constipation assessed by specific opioid medication, opioid dose, and duration of opioid use Abstract
Srinivas Nalamachu, MD, Jeffrey Gudin, MD, Catherine Datto, MD, MS, Karin Coyne, PhD, MPH, Jiat-Ling Poon, PhD, Yiqun Hu, MD, PhD
 
Vol 17, No 1 (2021): January/February Efficacy of target controlled infusion of remifentanil with spontaneous ventilation for procedural sedation and analgesia (Remi TCI PSA): A double center prospective observational study Abstract
Cyrus Motamed, MD, Romain Roubineau, MD, Jean-Pol Depoix, MD, Frédérique Servin, MD, Geraldine Roche, CRNA, Valérie Billard, MD
 
Vol 10, No 2 (2014): March/April Electrocardiographic and cardiovascular diagnostic characteristics of patients receiving long-term opioid therapy for pain Abstract
Jay W. Mason, MD, Ullrich S. Schwertschlag, MD, PhD, Vicki Klutzaritz, BS, Daniel M. Canafax, PharmD
 
Vol 1, No 5 (2005): November/December Electronically monitored single-use patient-controlled analgesia pumps in postoperative pain control Abstract   PDF
Michael Zimmermann, MD, Karin Friedrich, MD, Rolf Kirchner, MD
 
Vol 7, No 4 (2011): July/August Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts Abstract
Vesselin M. Chorbov, PhD, Alexandre A. Todorov, PhD, Michael T. Lynskey, PhD, Theodore J. Cicero, PhD
 
Vol 13, No 1 (2017): January/February Eleven years of children methadone poisoning in a referral center: A review of 453 cases Abstract
Hossein Hassanian-Moghaddam, MD, FACMT, Masumeh Hakiminejhad, MD, Fariba Farnaghi, MD, Amirhossein Mirafzal, MD, Nasim Zamani, MD, Ali Kabir, MD, MPH, PhD
 
Vol 16, No 4 (2020): July/August Emergency department patients’ perceptions of the efficacy and safety of opioid analgesics Abstract
Maryann Mazer-Amirshahi, PharmD, MD, MPH, PhD, Christie Sun, MD, Lydia Koroshetz, BS, Rui W. Soares Jr, BS, Anagha Kumar, MS, MA, MBA, Diane P. Calello, MD, Jeanmarie Perrone, MD, Lewis S. Nelson, MD
 
Vol 4, No 3 (2008): May/June Epidemiology of opioid pharmacy claims in the United States Abstract
Rachel E. Williams, PhD, MS, Timothy J. Sampson, BS, Linda Kalilani, MBBS, PhD, John I. Wurzelmann, MD, MPH, Stephen W. Janning, PharmD
 
Vol 4, No 3 (2008): May/June Epidural haloperidol enhances epidural morphine analgesia: Three case reports Abstract
George Colclough, MD, John T. McLarney, MD, Paul A. Sloan, MD, K. Todd McCoun, MD, Gregory L. Rose, MD, J. S. Grider, MD, P. Steyn, MD
 
Vol 10, No 7 (2014): Special Opioid REMS Educational Supplement ER/LA opioid REMS supplement Abstract
Paul A. Sloan, MD, Mellar P. Davis, MD, FCCP, Pamela Garnier, RN, BSN, CHPN
 
Vol 6, No 1 (2010): January/February EREM VERSUS IV PCA META-ANALYSIS Abstract
Robert H. Blackshear, MD, Shawn M. Sumida, MD, Jamie D. Murphy, MD, Christopher L. Wu, MD
 
Vol 12, No 2 (2016): March/April Establishing “abuse-deterrence equivalence” for generic abuse-deterrent opioid formulations: A proposed development framework Abstract
Beatrice Setnik, PhD, Edward J. Cone, PhD
 
Vol 1, No 1 (2005): March/April Establishing the safety and efficacy of an opioid titration protocol Abstract   PDF
Nancy Wells, DNSc, RN, Barbara Murphy, MD, Stacey Douglas, MSN, RN, Nancy Yelton, MSN, RN
 
Vol 11, No 1 (2015): January/February Evaluating motives: Two simple tests to identify and avoid entanglement in legally dubious urine drug testing schemes Abstract
Michael C. Barnes, Esq., Stacey L. Worthy, Esq
 
Vol 16, No 4 (2020): July/August Evaluating patients who present with pain complaints to a community hospital emergency department: Opioid prescription tracking software versus provider gestalt Abstract
Zach Hampton, DO, Justin Thai, DO, Christine Rukamp, DO, William Zackowski, DO, Danni Schneider, DO, Kimberly Cunagin, DO, Anand Gupta, MBBS, MPH, Andy Little, DO
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Evaluating the abuse potential of opioids and abuse-deterrent opioid formulations: A review of clinical study methodology Abstract
Beatrice Setnik, PhD, Kerri A. Schoedel, PhD, Naama Levy-Cooperman, PhD, Megan Shram, PhD, Glenn C. Pixton, MS, Carl L. Roland, PharmD, MS
 
Vol 16, No 3 (2020): May/June Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome Abstract
Rafia Q. Baloch, MD, Jamie M. Pinto, MD, Patricia Greenberg, MS, Yen-Hong Kuo, PhD, Anita Siu, PharmD, BCPPS
 
Vol 1, No 1 (2005): March/April Evaluation of cognitive functioning in 101 patients before opiate detoxification: Implications in setting up therapeutic strategies Abstract   PDF
Emmanuel Streel, MA, PhD, Valérie Antoniali, MA, Salvatore Campanella, MA, PhD, Julie Castronovo, MA, Catherine Hanak, MD, Isy Pelc, MD, PhD, Paul Verbanck, MD, PhD
 
Vol 6, No 3 (2010): May/June Evaluation of study discontinuations with tapentadol immediate release and oxycodone immediate release in patients with low back or osteoarthritis pain Abstract
Gary Vorsanger, PhD, MD, Jim Xiang, PhD, Akiko Okamoto, ScD, David Upmalis, MD, Bruce Moskovitz, MD
 
Vol 14, No 5 (2018): September/October Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER) Abstract
Diana Meske, PhD, Ernest A. Kopecky, PhD, Steven Passik, PhD, Megan J. Shram, PhD
 
Vol 7, No 6 (2011): November/December Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine Abstract
Suzanne K. Vosburg, PhD, Maria A. Sullivan, MD, PhD, Sandra D. Comer, PhD
 
Vol 10, No 3 (2014): May/June Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: Results of in vitro laboratory analyses Abstract
Eric Galia, PhD, Yinka Williams, PhD, Ben Van Hove, Joseph Pergolizzi, MD, Mila Etropolski, MD, Gary Vorsanger, PhD, MD
 
Vol 12, No 6 (2016): November/December Evaluation of treatment changes following electronic consultation to a pharmacist-run urine drug testing service in a veterans healthcare system Abstract
Michelle M. Stammet, PharmD, Shelley S. Spradley, PharmD, BCPS
 
Vol 15, No 1 (2019): January/February Exploratory study examining associations between prescription opioid dose and delay discounting in patients with chronic pain Abstract
Benjamin J. Morasco, PhD, Steven K. Dobscha, MD, Stephanie Hyde, MA, Suzanne H. Mitchell, PhD
 
Vol 1, No 2 (2005): May/June Extended-release lipid-foam encapsulated epidural morphine: Clinical efficacy and safety precautions Abstract   PDF
Rob Hutchison, PharmD
 
Vol 4, No 2 (2008): March/April Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain Abstract
Gary J. Vorsanger, PhD, MD, Jim Xiang, PhD, Theophilus J. Gana, MD, PhD, Maria Luz G. Pascual, MD, MPH, R. Rosanna B. Fleming, MS
 
Vol 8, No 4 (2012): July/August Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education Abstract
Susan C. Nicholson, MD, Kimberly Evanyo, BA, Gregory D. Salinas, PhD, Nancy Roepke, MBA, B. Stephen Burton, MS, Debi Susalka, BS
 
Vol 5, No 1 (2009): January/February Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules Abstract
Arnold J. Weil, MD, Bruce Nicholson, MD, John Sasaki, MD
 
Vol 16, No 3 (2020): May/June Factors associated with participation and nonparticipation in a VA Whole Health Primary Care Pain Education and Opioid Monitoring Program (PC-POP) Abstract
Amber Martinson, PhD, Amanda Kutz, PhD, William Marchand, MD, Julie Carney, RN, Jamie Clinton-Lont, MS, CNP
 
Vol 14, No 6 (2018): November/December Factors associated with the prevalence of neonatal abstinence syndrome in West Virginia Abstract
Taylor Rogerson, BSc, Anthony Houston II, BA, Garrett Lyman, BS, Jenna Ogden, BS, Kevin Paschall, BS, Mark Penaranda, BA, Alex Rios, BS, Robert Wetzel, MD, Joseph Horzempa, PhD
 
Vol 1, No 4 (2005): September/October Factors associated with willingness to participate in a heroin prescription program among injection drug users Abstract   PDF
Cari L. Miller, MSc, Steffanie A. Strathdee, PhD, Thomas Kerr, PhD, Will Small, MA, Kathy Li, MSc, Evan Wood, PhD
 
Vol 16, No 4 (2020): July/August Factors influencing the prescribed dose of opioid analgesics in cancer patients Abstract
Momoyo Hashimoto, MPharm, Kazuki Aogaki, BPharm, Chikako Numata, PhD, Kensuke Moriwaki, PhD, Yoshinobu Matsuda, MD, Ryouhei Ishii, MD, PhD, Ikuko Tanaka, BPharm, Yoshiaki Okamoto, PhD
 
Vol 3, No 6 (2007): November/December Family physicians’ proficiency in urine drug test interpretation Abstract
Gary M. Reisfield, MD, Fern J. Webb, PhD, Roger L. Bertholf, PhD, Paul A. Sloan, MD, George R. Wilson, MD
 
Vol 12, No 5 (2016): September/October FDA and Abuse Deterrent Opioids: Don’t fix the blame. Fix the problem Abstract
Peter J. Pitts
 
Vol 5, No 2 (2009): March/April FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse Abstract
James A. Inciardi, PhD, Hilary L. Surratt, PhD, Yamilka Stivers, BA, Theodore J. Cicero, PhD
 
Vol 11, No 1 (2015): January/February FDA/DEA/PDMP/UDT: Alphabet soup or sensible and integrated risk management? Abstract
Steven D. Passik, PhD, Kenneth L. Kirsh, PhD, Robert K. Twillman, PhD
 
Vol 15, No 5 (2019): September/October Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age Abstract
Amer Raheemullah, MD, Neal Andruska, MD, PhD
 
Vol 12, No 3 (2016): May/June Fentanyl in a pectin gel treating breakthrough pain Abstract
Borja Mugabure Bujedo, MD, Brynjar Karlsson, PhD
 
Vol 12, No 1 (2016): January/February Fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia for pain management following orthopedic surgery: A pooled analysis of randomized, controlled trials Abstract
Craig T. Hartrick, MD, Donald M. Knapke, MD, Li Ding, MS, MA, Hassan Danesi, MD, James B. Jones, MD
 
Vol 3, No 3 (2007): May/June Fentanyl: Are we paying too high a price? Abstract   PDF
Vincenzo Fodale, MD, Manuela Romeo, MD, Federica Mafrica, MD
 
Vol 1, No 2 (2005): May/June Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain Abstract   PDF
Katherine Ower, MD, FRCPC, Patricia Morley-Forster, MD, FRCPC, Dwight Moulin, MD, FRCPC
 
Vol 15, No 2 (2019): March/April Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with opioid use disorder in West Virginia Abstract
Shane W. Kaski, BS, MD/PhD, Stephan Brooks, MPH, Sijin Wen, PhD, Marc W. Haut, PhD, David P. Siderovski, PhD, James H. Berry, DO, Laura R. Lander, MSW, Vincent Setola, PhD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue From the editor Abstract
Paul A. Sloan, MD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue From the publisher Abstract
Richard A. DeVito, Jr
 
Vol 11, No 5 (2015): September/October Furosemide as a potential unintended urine drug screen confounder during methadone maintenance treatment Abstract
Rachel L. Bauer, PharmD, Wesley L. Geminn, PharmD, Jason A. Carter, PharmD
 
Vol 10, No 5 (2014): September/October Further validation of an opioid risk assessment tool: The Brief Risk Interview Abstract
Ted Jones, PhD, Samantha Lookatch, MA, Patricia Grant, MS, ANP-C, Janice McIntyre, MS, ANP-C, Todd Moore, PhD
 
Vol 9, No 3 (2013): May/June Gastrointestinal events after opioid treatment in nonmalignant pain: Correlates of occurrence and impact on health-related quality of life Abstract
Kate L. Lapane, PhD, Brian J. Quilliam, PhD, Carmela Benson, MS, Wing Chow, PharmD, MPH, Myoung S. Kim, PhD, MBA
 
Vol 2, No 4 (2006): July/August Getting Informed Consent and Agreement for Treatment right: A legal perspective on key obligations for practitioners who use controlled substances to treat chronic pain Abstract   PDF
Jennifer Bolen, JD
 
Vol 1, No 4 (2005): September/October Handbook of Pain Relief in Older Adults: An Evidence-Based Approach Abstract   PDF
Robert L. Barkin, PharmD, MBA, FCP, DAPPM
 
Vol 16, No 1 (2020): January/February Harnessing endogenous opioids for pain relief: Fantasy vs reality Abstract
Alan R. Gintzler, PhD, Nai-Jiang Liu, MD, PhD
 
Vol 2, No 6 (2006): November/December Healthcare professionals and the DEA: Restoring the balance Abstract   PDF
Howard A. Heit, MD, FACP, FASAM
 
Vol 15, No 6 (2019): November/December Hedonic eating behaviors and food preferences associated with medication-assisted treatment for opioid use disorder Abstract
Elizabeth McDonald, MS, FNP-BC, Jennifer Laurent, PhD, FNP-BC
 
Vol 8, No 4 (2012): July/August High dose of buprenorphine in terminally ill patient with liver failure: Efficacy and tolerability Abstract
Alessandra Ciccozzi, MD, Chiara Angeletti, MD, Giada Baldascino, MD, Emiliano Petrucci, MD, Cristina Bonetti, MD, Stefania De Santis, MD, Antonella Paladini, MD, Giustino Varrassi, PhD, Franco Marinangeli, MD
 
Vol 8, No 5 (2012): September/October High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model Abstract
Maria Cristina Monterubbianesi, MD, Jenny Capuccini, MD, Isabella Ferioli, MD, Davide Tassinari, MD, Donatella Sarti, PhD, William Raffaeli, MD
 
Vol 2, No 1 (2006): January/February High-dose methadone and QTc prolongation: Strategies to optimize safety Abstract   PDF
John Schmittner, MD, Mori J. Krantz, MD
 
Vol 11, No 6 (2015): November/December History of drug use predicts opioid treatment agreement violation Abstract
Pamela Summers, MD, MPH, Brook Alemu, MA, MPH, CPH, Antonio Quidgley-Nevares, MD
 
Vol 15, No 6 (2019): November/December Holistic approach to opioid use disorder: Think nitric oxide! Abstract
Marvin A. Sackner, MD, Jose R. Lopez, MD, Veronica Banderas, BA TR, Jose A. Adams. MD
 
Vol 4, No 5 (2008): September/October Hospital morbidity associated with the natural history of heroin use Abstract
Robert J. Tait, PhD, BSc (Hons), Gary K. Hulse, PhD, BBSc (Hons)
 
Vol 6, No 4 (2010): July/August Hydrocodone: Does it have a role in palliative care? Abstract
Eric Prommer, MD
 
Vol 10, No 5 (2014): September/October Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: A post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial Abstract
Srinivas Nalamachu, MD, Martin Hale, MD, Arif Khan, MD
 
Vol 14, No 1 (2018): January/February Hydromorphone use for acute pain: Misconceptions, controversies, and risks Abstract
Maryann Mazer-Amirshahi, PharmD, MD, MPH, Sergey Motov, MD, Lewis S. Nelson, MD
 
Vol 9, No 1 (2013): January/February Hypoglycemia during rapid methadone dose escalation Abstract
Natalie Moryl, MD, Joan Pope, NP, Eugenie Obbens, MD, PhD
 
Vol 11, No 3 (2015): May/June Hypogonadism associated with long-term opioid therapy: A systematic review Abstract
Pravardhan Birthi, MD, Vittal R. Nagar, MD, Robert Nickerson, MD, Paul A. Sloan, MD
 
Vol 17, No 2 (2021): March/April Hypogonadism in opioid using males in an inner-city cohort: A cross-sectional study Abstract
Leen Wehbeh, MD, Adrian S. Dobs, MD, MHS, Todd T. Brown, MD, PhD
 
Vol 2, No 1 (2006): January/February Iatrogenic addiction in patients treated for acute or subacute pain: A systematic review Abstract   PDF
Ajay D. Wasan, MD, MSc, Darin J. Correll, MD, Igor Kissin, MD, PhD, Sarah O’Shea, BA, Robert N. Jamison, PhD
 
Vol 17, No 1 (2021): January/February Iatrogenic addiction or dependence as a result of prescription oxycodone use in persons with chronic noncancer pain: A systematic review Abstract
Megan Dol, BSc, Mark Oremus, PhD
 
Vol 7, No 6 (2011): November/December Ideas and innovations: Inclusion of pharmacists in chronic pain management services in a primary care practice Abstract
Robin Moorman Li, PharmD, Rachel Hrabchak Franks, PharmD, Steven G. Dimmitt, DO, George R. Wilson, MD
 
Vol 16, No 6 (2020): November/December Identifying sociodemographic profiles of veterans at risk for high-dose opioid prescribing using classification and regression trees Abstract
Jacob S. Lipkin, MD, Joshua M. Thorpe, PhD, MPH, Walid F. Gellad, MD, MPH, Joseph T. Hanlon, PharmD, MS, Xinhua Zhao, PhD, Carolyn T. Thorpe, PhD, MPH, Florentina E. Sileanu, MS, John P. Cashy, PhD, Jennifer A. Hale, BA, Maria K. Mor, PhD, Thomas R. Radomski, MD, MS, Chester B. Good, MD, MPH, Michael J. Fine, MD, MSc, Leslie R. M. Hausmann, PhD
 
Vol 9, No 4 (2013): July/August Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: A randomized, phase IIIb study Abstract
Gary J. Vorsanger, PhD, MD, Angela M. Klopfer, BS, Jim Xiang, PhD, Carmela J. Benson, MS, Bruce L. Moskovitz, MD, Norman R. Rosenthal, MD
 
Vol 11, No 1 (2015): January/February Immunoassay in healthcare testing applications Abstract
Anne Z. DePriest, PharmD, BCPS, David L. Black, PhD, D-ABFT, Timothy A. Robert, PhD, D-ABCC
 
Vol 11, No 4 (2015): July/August Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey Abstract
Shaloo Gupta, MS, Haridarshan Patel, PharmD, Justin Scopel, MD, MBA, Reema R. Mody, MBA, PhD
 
Vol 16, No 6 (2020): November/December Impact of non-benzodiazepine sleep hypnotics on opioid overdose risk Abstract
Van Nguyen, PharmD, Christopher M. Herndon, PharmD, BCACP
 
Vol 13, No 4 (2017): July/August Impact of opioids on oxidative status and related signaling pathways: An integrated view Abstract
Maryam Zahmatkesh, PhD, Mehri Kadkhodaee, PharmD, PhD, Ali Salarian, MD, PhD student, Behjat Seifi, PhD, Soheila Adeli, PhD
 
Vol 10, No 4 (2014): July/August Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: An extended-release, abuse-deterrent formulation Abstract
Ernest A. Kopecky, PhD, MBA, Alison B. Fleming, PhD, Patrick K. Noonan, PhD, Ravi K. Varanasi, MPharm, Michael Grima, BS, Said Saim, PhD, Stephen P. Mayock, BS
 
Vol 14, No 4 (2018): July/August Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system Abstract
John W. Shumway, MD, Renzhong Ran, MD, Jeff McClusky, BS, Pharm, Zubaid Rafique, MD, Cedric Dark, MD, MPH, W. Frank Peacock, MD, Alexie Cintron, MD, Michelle Ludwig, MD, MPH, PhD
 
Vol 17, No 1 (2021): January/February Impact of the New York State Prescription Drug Monitoring Program (IStop) on chronic pain management by primary care providers Abstract
Josiah D. Strawser, MD, Lauren Block, MD, MPH
 
Vol 10, No 3 (2014): May/June Implementation of a collaborative care management program with buprenorphine in primary care: A comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically Abstract
Joji Suzuki, MD, Michele L. Matthews, PharmD, David Brick, BA, Minh-Thuy Nguyen, Robert N. N. Jamison, PhD, Andrew L. Ellner, MD, MSc, Lori W. Tishler, MD, Roger D. Weiss, MD
 
Vol 13, No 4 (2017): July/August Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality Abstract
Elyse Phillips, MPH, Julie Gazmararian, PhD, MPH
 
Vol 15, No 1 (2019): January/February Implications of use of opioid-containing analgesics for palliation of acute dental pain Abstract
Karunesh Chakote, DMD, James Guggenheimer, DDS
 
Vol 6, No 6 (2010): November/December Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS Abstract
Bridgit Crews, PhD, Sergey Latyshev, MS, Charles Mikel, PhD, Perla Almazan, CLS, MT (ASCP), Robert West, MS, Amadeo Pesce, PhD, DABCC, Cameron West, PhD
 
Vol 7, No 6 (2011): November/December Improvement of pain physicians’ practices of opioid management: Population-based urinary excretion data Abstract
Amadeo Pesce, PhD, DABCC, Bridgit Crews, PhD, Sergey Latyshev, MS, Charles Mikel, PhD, Perla Almazan, CLS, MT (ASCP), Robert West, MS, Murray Rosenthal, DO, FAPA, Cameron West, PhD
 
Vol 17, No 2 (2021): March/April Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person Abstract
Julienne K. Kirk, PharmD, CDE, BCPS, Matthew Q. Tran, PharmD, Samantha Pelc, PharmD, Katherine G. Moore, PharmD, BCPS, BCACP
 
Vol 8, No 6 (2012): November/December Improving use of narcotics for nonmalignant chronic pain: A lesson from Community Care of North Carolina Abstract
Ed Bujold, MD, FAAFP, Jessica Huff, MPH, Elizabeth W. Staton, MSTC, Wilson D. Pace, MD, FAAFP
 
Vol 15, No 2 (2019): March/April In Memorial: Professor Gavril Pasternak Abstract
Paul A. Sloan, MD
 
Vol 13, No 4 (2017): July/August In Memoriam - Robert B. Millman, MD Abstract
Carol J. Weiss, MD, Joyce Lowinson, MD
 
Vol 1, No 3 (2005): July/August In pain or drug-seeking? Resident continuity clinic, chronic nonmalignant pain, and addiction Abstract   PDF
Michael Weaver, MD
 
Vol 13, No 1 (2017): January/February In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone Abstract
D. Lynn Kirkpatrick, PhD, William K. Schmidt, PhD, Ricardo Morales, BSc, John Cremin, PhD, Julie Seroogy, BSc, Craig Husfeld, PhD, Thomas Jenkins, PhD
 
Vol 12, No 1 (2016): January/February In vitro assessment of the potential for abuse via the intravenous route of oxycodone DETERx® microspheres Abstract
Alison B. Fleming, PhD, Todd A. Scungio, BA, Michael P. Grima, BS, Stephen P. Mayock, BS
 
Vol 16, No 5 (2020): September/October In vitro evaluation of a novel immediate-release formulation of oxycodone (RoxyBond™) for the potential for abuse via injection Abstract
Eric R. Kinzler, PhD, Carmela Pantaleon, BS, Matthew Iverson, MPH, Stefan Aigner, MD
 
Vol 2, No 3 (2006): May/June Inaugural Opioid Certification Program Abstract   PDF
Christopher V. Rowland, Jr., MD, Editor
 
Vol 16, No 3 (2020): May/June Incidence and correlates of opioid-related psychiatric emergency care: A retrospective, multiyear cohort study Abstract
Anees Bahji, MD
 
Vol 15, No 5 (2019): September/October Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment Abstract
Mary M. Sweeney, MS, PhD, Denis G. Antoine, MD, Leticia Nanda, MS, CRNP, Hélène Géniaux, PharmD, Michelle R. Lofwall, MD, George E. Bigelow, PhD, Annie Umbricht, MD
 
Vol 4, No 5 (2008): September/October Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice Abstract
Kavita n. Manchikanti, BA, Laxmaiah Manchikanti, MD, Kimberly S. Damron, RN, Vidyasagar Pampati, MSc, Bert Fellows, MA
 
Vol 3, No 2 (2007): March/April Increasing prevalence of prescription opiate misuse over time among rural probationers Abstract   PDF
Jennifer R. Havens, PhD, MPH, Carrie B. Oser, PhD, Carl G. Leukefeld, DSW
 
Vol 16, No 5 (2020): September/October Independent risk factors for chronic illicit substance use during pregnancy Abstract
Manuel C. Vallejo, MD, DMD, Robert E. Shapiro, MD, Mitchell W. Lippy, BS, Christa L. Lilly, PhD, Leo R. Brancazio, MD
 
Vol 4, No 6 (2008): November/December Influence of prior opioid exposure on diagnostic facet joint nerve blocks Abstract
Laxmaiah Manchikanti, MD, Mark V. Boswell, MD, PhD, Rajeev Manchukonda, BDS, Kimberly A. Cash, RT, James Giordano, PhD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids Abstract
Christopher J. Miller, MS, Richard C. Dart, MD, Nathaniel P. Katz, MD, MS, Lynn R. Webster, MD, FACPM, FASAM
 
Vol 4, No 6 (2008): November/December Integration of viral hepatitis services into opioid treatment programs Abstract
Thomas F. Kresina, PhD, R. Douglas Bruce, MD, MA, MSc, Robert Lubran, MS, H. Westley Clark, MD, JD, FASAM
 
Vol 5, No 1 (2009): January/February Intensity and treatment of symptoms in 3,030 palliative care patients: A cross-sectional survey of the EAPC Research Network Abstract
Eivor Alette Laugsand, PhD-student, Stein Kaasa, MD, Franco de Conno, MD, Geoffrey Hanks, MD, Pål Klepstad, MD
 
Vol 13, No 2 (2017): March/April International Conference on Opioids Brochure and Schedule Details
Richard DeVito
 
Vol 8, No 4 (2012): July/August International Conference on Opioids, June 10-12, 2012 Abstract
Richard A. DeVito, Jr.
 
Vol 14, No 3 (2018): May/June International Conference on Opioids, June 10-12, 2018 - Photos Abstract
Richard A. DeVito, Jr.
 
Vol 14, No 3 (2018): May/June International Conference on Opioids, June 10-12, 2018 - Posters Abstract
Richard A. DeVito, Jr.
 
Vol 13, No 4 (2017): July/August International Conference on Opioids, June 11-13, 2017 Photos and Posters Abstract
Richard A. DeVito, Jr.
 
Vol 12, No 3 (2016): May/June International Conference on Opioids, June 5-7, 2016 Abstract
Richard A. DeVito, Jr.
 
Vol 11, No 4 (2015): July/August International Conference on Opioids, June 7-9, 2015 Details
Richard A. DeVito, Jr
 
Vol 9, No 4 (2013): July/August International Conference on Opioids, June 9-11, 2013: Photos, Presentations, and Posters Details
Richard A. DeVito, Jr
 
Vol 2, No 5 (2006): September/October Interpleural bupivacaine and intravenous oxycodone for pain treatment after thoracotomy in children Abstract   PDF
Hannu Kokki, MD, PhD, Merja Laisalmi, MD, Kari Vanamo, MD, PhD
 
Vol 8, No 3 (2012): May/June Interpretation of oxycodone concentrations in oral fluid Abstract
Christine Moore, PhD, Tara Kelley-Baker, PhD, John Lacey, MPH
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Interpreting labels of abuse-deterrent opioid analgesics Abstract
Lynn R. Webster, MD, FACPM, FASAM
 
Vol 5, No 1 (2009): January/February Interventional treatment of back pain in a patient with cancer Abstract
Paul Alexander Sloan, MD, J. S. Grider, DO, PhD
 
Vol 11, No 2 (2015): March/April Intractable pruritus during outpatient epidural hydromorphone infusion: A case report and a focused review of the literature Abstract
Xiulu Ruan, MD, Li Ma, MD, PhD, J. Patrick Couch, MD, Tao Chen, MD, PhD, Gary W. Bumgarner, PhD
 
Vol 5, No 6 (2009): November/December Intranasal abuse of prescription hydrocodone/acetaminophen results in oronasal fistula: A case report Abstract
Paul A. Sloan, MD, Oksana Klimkina, MD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users Abstract
Beatrice Setnik, PhD, Kerri Schoedel, PhD, Cindy Bartlett, MMath, Chris Dick, MS, MBA, Nasrat Hakim, MS, LLM, Pierre Geoffroy, MDCM, MSc, FCFP, DABAM
 
Vol 8, No 4 (2012): July/August Intranasal sufentanil provides adequate analgesia for emergency department patients with extremity injuries Abstract
Robert Stephen, MD, Erin Lingenfelter, PharmD, Camille Broadwater-Hollifield, MPH, Troy Madsen, MD
 
Vol 15, No 5 (2019): September/October Intraoperative opioid and non-opioid administration patterns and early postoperative pain: A single-center retrospective longitudinal study Abstract
Gregory Smith, MD, Marcel E. Durieux, MD, PhD, Siny Tsang, PhD, Bhiken I. Naik, MBBCh
 
Vol 4, No 5 (2008): September/October Intrathecal drug delivery for management of cancer and noncancer pain Abstract
Karen H. Simpson, FRCA, Iain Jones, FRCA
 
Vol 8, No 1 (2012): January/February Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose Abstract
Michael A. Yokell, ScB, Nickolas D. Zaller, PhD, Traci C. Green, PhD, MSc, Michelle McKenzie, MPH, Josiah D. Rich, MD, MPH
 
Vol 17, No 1 (2021): January/February Introduction of a modified analgesic ladder in the emergency department: Effect on oxycodone use for back pain Abstract
Jenny Ly, BPharm, GradCertPharmPrac, Cristina P. Roman, BPharm (Hons), MPP, Carl Luckhoff, MB, ChB, FACEM, Peter A. Cameron, MBBS, MD, FACEM, FCEM (Hon), Michael J. BPharm, GradDipHospPharm, PhD, AdvPracPharm, FSHP, FISOPP, Biswadev Mitra, MBBS, MHSM, PhD, FACEM
 
Vol 8, No 6 (2012): November/December Is opioid-induced hyperalgesia reversible? A study on active and former opioid addicts and drug naïve controls Abstract
Roi Treister, PhD, Elon Eisenberg, MD, Eli Lawental, DSW, Dorit Pud, PhD
 
Vol 4, No 1 (2008): January/February Is oral tramadol a reasonable PRN analgesic? Details
Christopher M. Herndon, PharmD, BCPS, Alexinna Johns, MD
 
Vol 10, No 2 (2014): March/April It made my life a little easier: Primary care providers’ beliefs and attitudes about using opioid treatment agreements Abstract
Joanna L. Starrels, MD, MS, Bryan Wu, MS, Deena Peyser, BA, Aaron D. Fox, MD, MS, Abigail Batchelder, MA, MPH, Frances K. Barg, PhD, MEd, Julia H. Arnsten, MD, MPH, Chinazo O. Cunningham, MD, MS
 
Vol 16, No 4 (2020): July/August IV tramadol: A novel option for US patients with acute pain—A review of its pharmacokinetics, abuse potential and clinical safety record Abstract
Lucy Lu, MD, Mark Harnett, MS, Scott A. Reines, MD, PhD
 
Vol 8, No 1 (2012): January/February January February 2012 Full Issue Abstract
Richard A. DeVito, Jr.
 
Vol 2, No 1 (2006): January/February JANUARY/FEBRUARY 2006 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 1 (2007): January/February January/February 2007; Volume 3, Number 1 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 4, No 1 (2008): January/February January/February 2008 Abstract
Richard A. DeVito, Jr.
 
Vol 5, No 1 (2009): January/February January/February 2009 Abstract
Richard A. DeVito, Jr.
 
Vol 6, No 1 (2010): January/February January/February 2010 Abstract
Richard A. DeVito, Jr.
 
Vol 7, No 1 (2011): January/February January/February 2011 Abstract
Richard A. DeVito, Jr.
 
Vol 13, No 1 (2017): January/February January/February 2017 Full Issue, Volume 13, Number 1 Abstract
Richard A. DeVito, Jr
 
Vol 10, No 4 (2014): July/August Journal of Opioid Management - Full Issue - V10 N4 - July/August 2014 Abstract
Full Issue
 
Vol 1, No 3 (2005): July/August July/August 2005 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 4 (2006): July/August July/August 2006 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 4 (2007): July/August July/August 2007 Abstract
Richard A. DeVito, Jr.
 
Vol 4, No 4 (2008): July/August July/August 2008 Abstract
Richard A. DeVito, Jr.
 
Vol 5, No 4 (2009): July/August July/August 2009 Abstract
Richard A. DeVito, Jr.
 
Vol 6, No 4 (2010): July/August JULY/AUGUST 2010 Abstract
Richard A. DeVito, Jr.
 
Vol 7, No 4 (2011): July/August July/August 2011 Abstract
Richard A. DeVito, Jr.
 
Vol 9, No 4 (2013): July/August July/August 2013 Volume 9, Number 4 Abstract
Richard A. DeVito, Jr.
 
Vol 4, No 3 (2008): May/June Ketamine for acute and subacute pain in opioid-tolerant patients Abstract
Shoshana Chazan, RN, Margaret P. Ekstein, MD, Nissim Marouani, MD, Avi A. Weinbroum, MD
 
Vol 15, No 6 (2019): November/December Key characteristics and habits of the recreational opioid user Abstract
Anna Schinas, MSc, Shein Nanji, BSc, Kira Vorobej, MSc, Catherine Mills, MSc, Dawn Govier, BSc, Beatrice Setnik, PhD
 
Vol 3, No 2 (2007): March/April King of Pain: What Elvis’s death tells us about media coverage of celebrities and the pain/addiction interface Abstract   PDF
Steven D. Passik, PhD, Kenneth L. Kirsh, PhD
 
Vol 15, No 1 (2019): January/February Knowledge and implementation of current opioid guidelines among healthcare providers in Manitoba Abstract
Diana C. Sanchez-Ramirez, PhD, MPH, PT, Christine Polimeni, MD
 
Vol 15, No 6 (2019): November/December Knowledge gaps and practice patterns of clinicians treating patients with opioid use disorder Abstract
Maziar Rasulnia, PhD, Billy Stephen Burton, MS, Dhiren Patel, PharmD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 Testing Abstract
Christopher Altomare, BS, Eric R. Kinzler, PhD, August R. Buchhalter, PhD, Edward J. Cone, PhD, Anthony Costantino, PhD
 
Vol 10, No 4 (2014): July/August Lack of correlation between the effective dose of fentanyl sublingual spray for breakthrough cancer pain and the around-the-clock opioid dose Abstract
Srinivas R. Nalamachu, MD, Neha Parikh, Larry Dillaha, MD, Richard Rauck, MD
 
Vol 11, No 1 (2015): January/February Letter from the Editor, Publisher Abstract
Richard A. DeVito, Jr, Paul Alexander Sloan, MD
 
Vol 8, No 6 (2012): November/December Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department Abstract
Shailendra Kapoor, MD
 
Vol 10, No 2 (2014): March/April Letter to the editor. Mehendale Aw, Goldman MP, Mehendale RP: OPIOID Overuse Pain Syndrome (Oops): The story of opioids, Prometheus unbound. J Opioid Manag. 2013; 9(6): 421-438. Abstract
Laxmaiah Manchikanti, MD, Sairam Atluri, MD, Mark V. Boswell, MD, PhD, Hans C. Hansen, MD, Anand Mehendale, MD, Mark P. Goldman, PhD, Rachel P. Mehendale, BA
 
Vol 11, No 2 (2015): March/April Letters to the editor Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD, Xiulu Ruan, MD, Li Ma, MD, PhD, Ngoc Vo, MEd, Srinivas Chiravuri, MD, Devavrat G. Harshe, MD, Omkar S. Mate, DPM, DNB, Rashmin M. Cholera, DPM, DNB, Sanjiv S. Kale
 
Vol 17, No 2 (2021): March/April Limited use of nonopioid analgesics after pediatric ambulatory surgery Abstract
Nhi Ho, MD, Anjali A. Dixit, MD, MPH, Christina Inglis-Arkell, MD, Solmaz P. Manuel, MD
 
Vol 2, No 6 (2006): November/December Linkage to methadone treatment from acute opiate detoxification treatment Abstract   PDF
Nickolas D. Zaller, PhD, Portia Thurmond, MPH, Jon Brett, PhD, James C. Carleton, MS, Josiah D. Rich, MD, MPH
 
Vol 3, No 5 (2007): September/October Locally invasive and metastatic endometrial cancer: Multiple issues functioning in a multidirectional manner Abstract
Bruce Z. Kaplan, MD, Reed Phillips, MD, Dan Ratner, BA
 
Vol 8, No 3 (2012): May/June Long-term opioid therapy, aberrant behaviors, and substance misuse: Comparison of patients treated by resident and attending physicians in a general medical clinic Abstract
Jessica L. Colburn, MD, Donald R. Jasinski, MD, Darius A. Rastegar, MD
 
Vol 14, No 2 (2018): March/April Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use Abstract
Anna D. Coutinho, BPharm, PhD, Kavita Gandhi, BPharm, MS, Rupali M. Fuldeore, BAMS, MS, Pamela B. Landsman-Blumberg, MPH, DrPH, Sanjay Gandhi, PhD
 
Vol 6, No 5 (2010): September/October Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients Abstract
Russell K. Portenoy, MD, William Raffaeli, MD, Luis M. Torres, MD, Thomas Sitte, Akhil Chandra Deka, MD, Ileana Gonzalez Herrera, MD, Mark S. Wallace, MD
 
Vol 5, No 2 (2009): March/April Long-term safety, tolerability, and efficacy of OROS® hydromorphone in patients with chronic pain Abstract
Mark Wallace, MD, Dwight E. Moulin, MD, Richard L. Rauck, MD, Sarita Khanna, PhD, Iulia Cristina Tudor, PhD, Roman Skowronski, MD, John Thipphawong, MD
 
Vol 6, No 3 (2010): May/June Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer Abstract
Neal E. Slatkin, MD, Michelle I. Rhiner, RN, MSN, NP, Errol M. Gould, PhD, Tina Ma, PhD, Harry Ahdieh, PhD
 
Vol 13, No 3 (2017): May/June Looking both ways before crossing the street: Assessing the benefits and risk of opioids in treating patients at risk of sleep disordered breathing for pain and dyspnea Abstract
Mellar P. Davis, MD, FCCP, FAAHPM, Bertrand Behm, MD, Diwakar Balachandran, MD
 
Vol 9, No 4 (2013): July/August Loperamide: From antidiarrheal to analgesic Abstract
Rakesh Kumar, MSc, PhD
 
Vol 8, No 3 (2012): May/June Loss of antinociceptive effectiveness of morphine and oxycodone following titration of levothyroxine: Case reports and a brief review of published literature Abstract
Theresa A. Matoushek, PharmD, Tina C. Kearney, MD, Tammy J. Lindsay, MD, FAAFP, Christopher M. Herndon, PharmD, BCPS, CPE, FASHP
 
Vol 4, No 4 (2008): July/August Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: A case report Abstract
Scott Hamann, MD, PhD, Paul Alexander Sloan, MD, William Witt, MD
 
Vol 15, No 2 (2019): March/April Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome Abstract
Jamie L. Miller, PharmD, BCPS, BCPPS, FPPAG, Kimberly Ernst, MD, MSMI, FAAP, Stephen B. Neely, MPH, Katy Stephens, BS, Philip Barker, Grant H. Skrepnek, PhD, RPh, Peter N. Johnson, PharmD, BCPS, BCPPS, FPPAG, FCCM
 
Vol 2, No 5 (2006): September/October Malignant pain or malignant patients? Abstract   PDF
Michael Weaver, MD
 
Vol 4, No 4 (2008): July/August Management of chronic nonmalignant pain: A needs assessment in an Internal Medicine Resident Continuity Clinic Abstract
Leanne M. Yanni, MD, Michael F. Weaver, MD, Betty A. Johnson, MD, PhD, Laura A. Morgan, PharmD, Sarah E. Harrington, MD, Jessica M. Ketchum, PhD
 
Vol 16, No 3 (2020): May/June Managing breakthrough pain for advanced malignancy in elderly patients: A real challenge Abstract
Deepti Ahuja, MD, Nandan Choudhary, MD, Vinod Kumar, MD, Nishkarsh Gupta, MD, Sachidanand Jee Bharati, DM
 
Vol 15, No 4 (2019): July/August Mania induced by tramadol-venlafaxine combination Abstract
Nousha Hefzi, BA, MBA, Jeremy Grekin, MS, Aisha Ahmed, MD
 
Vol 1, No 1 (2005): March/April March/April 2005 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 2 (2006): March/April MARCH/APRIL 2006 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 2 (2007): March/April MARCH/APRIL 2007 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 4, No 2 (2008): March/April March/April 2008 Abstract
Richard A. DeVito, Jr.
 
Vol 5, No 2 (2009): March/April March/April 2009 Abstract
Richard A. DeVito, Jr.
 
Vol 6, No 2 (2010): March/April March/April 2010 Abstract
Richard A. DeVito, Jr.
 
Vol 7, No 2 (2011): March/April March/April 2011 Abstract
Richard A. DeVito, Jr.
 
Vol 8, No 2 (2012): March/April March/April 2012 Abstract
Richard A. DeVito, Jr.
 
Vol 1, No 2 (2005): May/June May/June 2005 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 3 (2006): May/June MAY/JUNE 2006 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 3 (2007): May/June MAY/JUNE 2007 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 4, No 3 (2008): May/June May/June 2008 Abstract
Richard A. DeVito, Jr.
 
Vol 5, No 3 (2009): May/June May/June 2009 Abstract
Richard A. DeVito, Jr.
 
Vol 6, No 3 (2010): May/June MAY/JUNE 2010 Abstract
Richard A. DeVito, Jr.
 
Vol 7, No 3 (2011): May/June May/June 2011 Abstract
Richard A. DeVito, Jr.
 
Vol 15, No 3 (2019): May/June May/June 2019 Abstract
Journal of Opioid Management
 
Vol 12, No 1 (2016): January/February Measurement of neonatal abstinence syndrome: Evaluation of short forms Abstract
Hendrée E. Jones, PhD, Carl Seashore, MD, Elisabeth Johnson, FNP, PhD, Evette Horton, PhD, Kevin E. O’Grady, PhD, Kim Andringa, PhD
 
Vol 15, No 4 (2019): July/August Measuring opioid dependence in chronic pain patients: A comparison between addiction clinic and pain clinic patient populations Abstract
Mike McDonough, MBBS, Jacinta L. Johnson, PhD, Jason M. White, PhD, Femke T. A. Buisman-Pijlman, PhD
 
Vol 5, No 5 (2009): September/October Medical cannabis Details
Gilbert J. Fanciullo MD, MS
 
Vol 10, No 5 (2014): September/October Medical resource use and costs among pain patients with potential opioid-tolerability issues Abstract
Noam Y. Kirson, PhD, Amie Shei, PhD, Howard G. Birnbaum, PhD, Rami Ben-Joseph, PhD, Edward Michna, MD
 
Vol 3, No 4 (2007): July/August Medication errors with opioids: Results from a national reporting system Abstract
Sydney Morss Dy, MD, MSc, Andrew D. Shore, PhD, Rodney W. Hicks, PhD, ARNP, Laura L. Morlock, PhD
 
Vol 11, No 1 (2015): January/February Medication monitoring and drug testing ethics project Abstract
Richard Payne, MD, Jeffrey L. Moe, PhD, Catherine Harvey Sevier, DrPH, David Sevier, MS, Michael Waitzkin, JD, LLM
 
Vol 5, No 3 (2009): May/June Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions Abstract
Sunil K. Aggarwal, PhD, Gregory T. Carter, MD, MS, Mark D. Sullivan, MD, PhD, Craig ZumBrunnen, PhD, Richard Morrill, PhD, Jonathan D. Mayer, PhD
 
Vol 15, No 3 (2019): May/June Medicolegal liability of patients driving under the influence (DUI) Abstract
Deepak Gupta, MD, Shushovan Chakrabortty, MD, PhD
 
Vol 3, No 1 (2007): January/February Medicolegal rounds: Medicolegal issues and alleged breaches of standards of medical care in a patient motor vehicle accident allegedly related to chronic opioid analgesic therapy Abstract   PDF
David A. Fishbain, MD, FAPA, John E. Lewis, PhD, Brandly Cole, PsyD, Renné Steele Rosomoff, BSN, MBA, Hubert L. Rosomoff, MD, DMedSc, FAAPM
 
Vol 5, No 5 (2009): September/October Meta-analysis of the effect of extended-release epidural morphine versus intravenous patient-controlled analgesia on respiratory depression Abstract
Shawn Sumida, MD, Maggie R. Lesley, BS, Marie N. Hanna, MD, Jamie D. Murphy, MD, Kanupriya Kumar, MD, Christopher L. Wu, MD
 
Vol 5, No 2 (2009): March/April Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs) Abstract
Craig D. Blinderman, MD, MA, Ryuichi Sekine, MD, Baohui Zhang, MS, Matthew Nillson, MS, Lauren Shaiova, MD
 
Vol 12, No 2 (2016): March/April Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients Abstract
Alexandra Fife, PharmD, Andrea Postier, MPH, Andrew Flood, PhD, Stefan J. Friedrichsdorf, MD, FAAP
 
Vol 2, No 5 (2006): September/October Methadone for cancer-related neuropathic pain: A review of the literature Abstract   PDF
Rosemarie Mannino, MD, Patrick Coyne, MSN, APRN, Craig Swainey, MD, Lea Ann Hansen, PharmD, Laurie Lyckholm, MD
 
Vol 1, No 5 (2005): November/December Methadone in end-of-life pain management Abstract   PDF
Diane L. Chau, MD, M. Nathan Mason, MD
 
Vol 12, No 2 (2016): March/April Methadone prolongs cardiac conduction in young patients with cancer-related pain Abstract
Doralina L. Anghelescu, MD, Rakesh M. Patel, MD, Daniel P. Mahoney, MD, Luis Trujillo, MD, Lane G. Faughnan, BSN, Brenda D. Steen, MSN, Justin N. Baker, MD, Deqing Pei, MS
 
Vol 7, No 5 (2011): September/October Methadone use in children and young adults at a cancer center: A retrospective study Abstract
Doralina L. Anghelescu, MD, Lane G. Faughnan, RN, Gisele M. Hankins, RN, Deborah A. Ward, PharmD, Linda L. Oakes, RN, CNS
 
Vol 1, No 4 (2005): September/October Methadone-related deaths Abstract   PDF
Lynn R. Webster, MD
 
Vol 5, No 6 (2009): November/December Methylnaltrexone potentiates body weight and fat reduction with leptin Abstract
Chun-Su Yuan, MD, PhD, Shi Sun, PhD, Anoja Attele, MD, Chong-Zhi Wang, PhD, Robin Tong, BS, Robert J. Israel, MD
 
Vol 5, No 4 (2009): July/August Methylnaltrexone reduced body weight gain in ob/ob mice Abstract
Chun-Su Yuan, MD, PhD, Chong-Zhi Wang, PhD, Anoja Attele, MD, Liu Zhang, PhD
 
Vol 5, No 4 (2009): July/August Midazolam as an antiemetic in patients receiving epidural morphine for postoperative pain relief Abstract
Mokhtar Elhakim, MD, Hany Abd Elfattah, MD, Dalia Nasr El-Din, MD, Reem El-Kabarity, MD, Azia Atef, MD, Atef El-Fakey, MD
 
Vol 12, No 1 (2016): January/February Minimizing stress with remifentanil in a patient with Takotsubo undergoing ophthalmic surgery Abstract
Sbaraglia Fabio, MD, Garra Rossella, MD, De Riso Mariella, MD, Continolo Nicola, MD, Sammartino Maria, MD
 
Vol 2, No 3 (2006): May/June Modafinil: Is it ready for prime time? Abstract   PDF
Eric Prommer, MD
 
Vol 1, No 5 (2005): November/December Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the Pain Assessment and Documentation Tool Abstract   PDF
Steven D. Passik, PhD, Kenneth L. Kirsh, PhD, Laurie Whitcomb, MA, Jeffrey R. Schein, PhD, MPH, Mitchell A. Kaplan, PhD, Sheri L. Dodd, MSc, Leah Kleinman, PhD, Nathaniel P. Katz, MD, Russell K. Portenoy, MD
 
Vol 10, No 1 (2014): January/February Monitoring oxycodone use in patients with chronic pain: Analysis of oxycodone and metabolite excretion in saliva and urine Abstract
Kathleen V. Moy, MS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS
 
Vol 1, No 2 (2005): May/June Morphine analgesia in cancer pain: Role of the glucuronides Abstract   PDF
Richard T. Penson, MRCP, MD, Simon P. Joel, PhD, Anna Gloyne, BSc, Simon Clark, BSc, Maurice L. Slevin, FRCP, MD
 
Vol 7, No 2 (2011): March/April Morphine and cancer progression: Hydrogen peroxide points to need for more research Abstract
Herbert Bosshart, MD
 
Vol 8, No 4 (2012): July/August Morphine clearance in children: Does race or genetics matter? Abstract
Senthilkumar Sadhasivam, MD, MPH, Elke H. J. Krekels, MSc, Vidya Chidambaran, MD, Hope R. Esslinger, MPT, Pornswan Ngamprasertwong, MD, Kejian Zhang, MD, MBA, Tsuyoshi Fukuda, PhD, Alexander A. Vinks, PharmD, PhD
 
Vol 3, No 1 (2007): January/February Morphine prescription in end-of-life care and euthanasia: French home nurses’ opinions Abstract   PDF
Marc Karim Bendiane, PhDc, Anne-Deborah Bouhnik, PhDc, Roger Favre, PhD, Anne Galinier, MD, Yolande Obadia, MD, Jean-Paul Moatti, PhD, Patrick Peretti-Watel, PhD
 
Vol 1, No 1 (2005): March/April Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians’ attitudes Abstract   PDF
Marc K. Bendiane, MSC, Patrick Peretti-Watel, PhD, Herve Pegliasco, MD, Roger Favre, PhD, Anne Galinier, MD, Jean-Marc Lapiana, MD, Yolande Obadia, MD
 
Vol 2, No 3 (2006): May/June Morphine toxicity in renal failure Abstract   PDF
Ferraz Gonçalves, MD
 
Vol 10, No 5 (2014): September/October MT-45: A new, dangerous legal high Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD
 
Vol 16, No 6 (2020): November/December Narcotic use in patients following a traumatic injury Abstract
Audis Bethea, PharmD, BCPS, BCCCP, Damayanti Samanta, MS, Kellie Amodeo, MD
 
Vol 16, No 3 (2020): May/June National gender differences in the prescribing of opioid medications from 2006 to 2015 Abstract
Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD
 
Vol 5, No 1 (2009): January/February Nebulized morphine for analgesia in an emergency setting Abstract
Vincent Bounes, MD, Jean Louis Ducassé, MD, Annie Momo Bona, MD, Florent Battefort, MD, Charles-Henri Houze-Cerfon, MD, Dominique Lauque, MD
 
Vol 6, No 6 (2010): November/December Neonatal abstinence scores in opioid-exposed and nonexposed neonates: A blinded comparison Abstract
Hendrée E. Jones, PhD, Cheryl Harrow, RN-LRN, MS, FNP-BC, IBCLC, Kevin E. O’Grady, PhD, Michael Crocetti, MD, Lauren M. Jansson, MD, Karol Kaltenbach, PhD
 
Vol 1, No 1 (2005): March/April News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 2 (2005): May/June News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 3 (2005): July/August News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 4 (2005): September/October News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 5 (2005): November/December News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 1 (2006): January/February News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 2 (2006): March/April News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 1 (2007): January/February News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
251 - 500 of 900 Items << < 1 2 3 4 > >>